To see the full article, log in or purchase access. Rifampicin is well tolerated by most patients at currently recommended doses, although gastrointestinal intolerance can be unacceptably severe. Published online Jul Timing of initiation of antiretroviral therapy in human immunodeficiency virus HIV -associated tuberculous meningitis. There is evidence showing the patient has clinically significant metabolic, gastrointestinal, neurological, psychiatric or endocrine diseases, malignancy, or other abnormalities other than the indication being studied. Available for Android and iOS devices.
Usual Adult Dose for Meningococcal Meningitis Prophylaxis
Treatment Regimens for Latent TB Infection (LTBI)
Contributor Information Meredith Milstein, Email: Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered. In all instances, the dose of the lopinavir component was mg twice daily and the nucleoside analogue dosing was standard. Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease. First, with regard to the adverse events, we implicated specific drugs ritonavir and rifampicin but cannot exclude a role for other drugs including the NRTIs and other anti-tuberculosis drugs in the standard TB treatment regimen including isoniazid. Click here for additional data file.
The trial will be set in two hospitals in Uganda: Causality in relation to study drug rifampicin is assessed as unrelated, unlikely, possible, probable or definite based on temporal relationship and clinical judgement. There is any evidence showing that the patient has renal impairment, including but not limited to serum creatinine levels above the upper limit of the laboratory reference range. Layout table for eligibility information Ages Eligible for Study: By September more than , treatment courses had been ordered. Take 30 to 60 minutes before OR 2 hours after meals with a full glass of water. Dissemination of trial findings The study principal investigators hold primary responsibility for the preparation of publications.